VUQUILSO
Live / Registered — Registered (as of 14 May 2024)
What this means for you
Registered since 14 May 2024. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 14 May 2030: the §8 declaration of use).
Record
- Serial number
- 97125161
- Registration number
- 7383698
- Mark type
- Word mark
- Filed
- 15 Nov 2021
- Published for opposition
- 27 Feb 2024
- Registered
- 14 May 2024
- Next maintenance filing
- §8 declaration of use, due by 14 May 2030 (grace period to 14 Nov 2030)
- Attorney of record
- Elizabeth K. Rucki
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders
Owner
- Glaxo Group Limited, Stevenage, GB
- Glaxo Group Limited, Stevenage, GB
- Glaxo Group Limited, Brentford, Middlesex, GB
Prosecution history
- 14 May 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 14 May 2024 — REGISTERED-PRINCIPAL REGISTER
- 04 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 27 Feb 2024 — PUBLISHED FOR OPPOSITION
- 07 Feb 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 Feb 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 23 Jan 2024 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 23 Jan 2024 — PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
- 17 Jan 2024 — ASSIGNED TO PETITION STAFF
- 06 Dec 2023 — TEAS PETITION TO AMEND BASIS RECEIVED
- 24 Nov 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Nov 2023 — SOU EXTENSION 2 GRANTED
- 22 Nov 2023 — SOU EXTENSION 2 FILED
- 22 Nov 2023 — SOU TEAS EXTENSION RECEIVED
- 09 Oct 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED